Get the Stockscreener App
51.94
0.57%
-0.33
After Hours:
51.89
-0.05
-0.10%
Phibro Animal Health Corp stock is traded at $51.94, with a volume of 133.30K.
It is down -0.57% in the last 24 hours and up +26.76% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$52.27
Open:
$52.46
24h Volume:
133.30K
Relative Volume:
0.52
Market Cap:
$2.10B
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
140.38
EPS:
0.37
Net Cash Flow:
$37.02M
1W Performance:
-2.13%
1M Performance:
+26.76%
6M Performance:
+33.02%
1Y Performance:
+115.91%
1-Day Range:
$51.58
$53.01
1-Week Range:
$51.03
$55.99
52-Week Range:
$16.16
$56.30
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
51.93 | 2.12B | 982.01M | 14.80M | 37.02M | 0.37 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.98 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.48 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.88 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
Ex-Dividend Reminder: Phibro Animal Health, Pjt Partners and Equitable Holdings - Nasdaq
Phibro Animal Health's CEO Sold Over 14,000 Shares. Is the Stock a Buy or Sell? - Yahoo Finance
Zacks.com featured highlights include Crocs, LATAM Airlines, Arrow Electronics and Phibro Animal Health - Yahoo Finance
Phibro Animal Health (PAHC) director sells $1.1 million in stock By Investing.com - Investing.com South Africa
Phibro Animal Health (PAHC) CEO-linked LLC sells 21,120 shares - Stock Titan
Phibro at BofA Securities Summit: Strategic Growth and Integration - Investing.com
Phibro Animal Health Corp. Achieves 124.29% Return, Emerging as a Multibagger in Pharmaceuticals Sector - Markets Mojo
Insider entity BFI Co. LLC trims Phibro Animal Health (PAHC) stake - Stock Titan
What Phibro Animal Health (PAHC)'s Stronger Q2 and Maturing Feed Additive Portfolio Mean For Shareholders - Yahoo Finance
PAHC Technical Analysis & ETF Price Forecast - Intellectia AI
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - Yahoo Finance
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - The Motley Fool
Phibro Animal Health Corporation (NASDAQ:PAHC) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Best Momentum Stocks to Buy for February 20th - Yahoo Finance
Best Value Stocks to Buy for February 20th - Yahoo Finance
Assessing Phibro Animal Health (PAHC) Valuation After Strong Share Price Momentum - Yahoo Finance
Zacks Research Issues Positive Forecast for PAHC Earnings - MarketBeat
Weekly Earnings: Is Phibro Animal Health Corporation forming a breakout patternBull Run & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit - marketscreener.com
Morgan Stanley Maintains Equal Weight on Phibro Animal Health Corporation (PAHC), Cites Margin Expansion - Insider Monkey
Rule 10b5-1 sales by Phibro (PAHC) entity tied to CEO Bendheim - Stock Titan
Will Phibro Animal Health Corporation benefit from sector rotation2025 Price Momentum & Trade Opportunity Analysis - mfd.ru
Will Phibro Animal Health Corporation benefit from AI trends2025 Volume Leaders & Reliable Price Breakout Signals - baoquankhu1.vn
Form 4: David Glenn reports acquisition/exercise transactions in PAHC - Stock Titan
Aug Rallies: Is Phibro Animal Health Corporation gaining market shareJuly 2025 Review & Risk Managed Trade Strategies - baoquankhu1.vn
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Why Phibro (PAHC) International Revenue Trends Deserve Your Attention - Yahoo Finance
Penserra Capital Management LLC Makes New $519,000 Investment in Phibro Animal Health Corporation $PAHC - Defense World
Phibro Animal Health Signals Strong Momentum in Earnings - TipRanks
Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12 - Yahoo Finance
Phibro Animal Health Corporation (NASDAQ:PAHC) Q2 2026 Earnings Call Transcript - Insider Monkey
3 Reasons Growth Investors Will Love Phibro (PAHC) - Yahoo Finance
Phibro Animal Health (PAHC) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
Phibro Animal Health Corporation $PAHC Shares Sold by Ranger Investment Management L.P. - MarketBeat
Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Phibro Animal Health Q2 Earnings Call Highlights - Yahoo Finance
Phibro Animal Health (PAHC) Margin Rebound And EPS Surge Test Cautious Growth Narratives - simplywall.st
Phibro Animal Health (PAHC) Is Up 25.3% After Issuing 2026 Sales And EPS GuidanceWhat's Changed - Yahoo Finance
Phibro Animal Health Corp (PAHC) Q2 2026 Earnings Call Highlight - GuruFocus
Phibro Animal Health Corp (PAHC) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ... By GuruFocus - Investing.com Canada
Phibro Animal Health stock hits 52-week high at $46.95 - Investing.com
Phibro Animal Health now targets up to 85% profit growth in 2026 - Stock Titan
Hershey Posts Upbeat Q4 Earnings, Joins FormFactor, ITT, Cardinal Health And Other Big Stocks Moving Higher On Thursday - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Phibro Q2 2026 presentation: Animal Health drives 21% revenue growth, guidance raised - Investing.com
Earnings call transcript: Phibro Animal Health beats Q2 2026 forecasts, stock surges - Investing.com
Chart Watch: What is the long term forecast for Phibro Animal Health Corporation stockQuarterly Growth Report & Verified Short-Term Plans - baoquankhu1.vn
Phibro Animal Health Fiscal Q2 Adjusted Earnings, Sales Rise; Lifts FY26 Outlook; Shares Soar Premarket - marketscreener.com
Decoding Phibro Animal Health Corp (PAHC): A Strategic SWOT Insi - GuruFocus
Compared to Estimates, Phibro (PAHC) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Misses Q2 CY2026 Revenue Estimates, But Stock Soars 5.5% - Finviz
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):